'Rational drug design' identifies fragments of FDA-approved drugs relevant to emerging viruses

A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the basis for new medicines -- if emerging viruses such as the H5N1(avian flu) or H1N1/09 (swine flu) develop resistance to current antiviral therapies -- according to a presentation at the American Society for Cell Biology 49th Annual Meeting, Dec. 5-9, 2009 in San Diego.

Read the whole article on Physorg

More from Physorg